Public Profile

Ipsen

Ipsen S.A., a global biopharmaceutical group headquartered in France, has established itself as a leader in the healthcare industry since its founding in 1929. With a strong presence in Europe, North America, and Asia, Ipsen focuses on innovative treatments in oncology, neuroscience, and rare diseases. The company is renowned for its core products, including Somatuline® and Cabometyx®, which are distinguished by their unique mechanisms of action and efficacy in treating complex conditions. Ipsen's commitment to research and development has led to significant milestones, including the expansion of its product portfolio and strategic partnerships that enhance its market position. Recognised for its dedication to patient care and innovation, Ipsen continues to make strides in the biopharmaceutical sector, contributing to advancements that improve the quality of life for patients worldwide.

DitchCarbon Score

How does Ipsen's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

55

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

22

Industry Benchmark

Ipsen's score of 55 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.

98%

Ipsen's reported carbon emissions

In 2023, Ipsen reported total greenhouse gas emissions of approximately 11,516,000 kg CO2e for Scope 1, 6,588,000 kg CO2e for Scope 2, and 21,248,000 kg CO2e for Scope 3. This reflects a commitment to reducing absolute Scope 1 and 2 emissions by 50% by 2030 from a 2019 baseline, alongside a 20% reduction target for Scope 3 emissions within the same timeframe. In 2022, Ipsen's emissions were approximately 11,920,000 kg CO2e (Scope 1), 6,890,000 kg CO2e (Scope 2), and 17,956,000 kg CO2e (Scope 3). The company has demonstrated a consistent approach to managing its carbon footprint, with a notable decrease in Scope 1 emissions from 14,316,000 kg CO2e in 2019 to 11,516,000 kg CO2e in 2023. Ipsen's climate commitments align with the Science Based Targets initiative (SBTi), ensuring that their reduction targets are consistent with the global aim to limit warming to 1.5°C. The company is also committed to achieving net-zero emissions across all scopes by 2050. These initiatives reflect Ipsen's dedication to sustainability and responsible environmental stewardship within the pharmaceutical sector.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2019202120222023
Scope 1
14,316,000
00,000,000
00,000,000
00,000,000
Scope 2
4,343,000
0,000,000
0,000,000
000,000
Scope 3
29,861,000
00,000,000
00,000,000
00,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Ipsen's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Ipsen is headquartered in FR, which has a rank of very low, indicating very low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Ipsen is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Was this information valuable to you?

Similar Organizations

Allergan

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 24 days ago

Lundbeck

DK
Health and social work services (85)
Updated 1 day ago

Celgene Corporation

US
Chemicals nec
Updated about 1 month ago
DitchCarbon Score

Bms

US
Chemicals nec
Updated about 19 hours ago

Chiesi Farmaceutici

IT
Medical, precision and optical instruments, watches and clocks (33)
Updated 6 days ago

Teva Pharmaceuticals

IL
Chemicals nec
Updated about 4 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers